KCNN3 gene
Evidence from:
primary |
all sources
Related entities (4)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| KCNN3 | expressed_in | brain | — | 1 |
| KCNN3 | regulates | long-term potentiation | — | 1 |
| KCNN3 | associated_with | nicotine | — | 1 |
| KCNN3 | associated_with | schizophrenia | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Intranasal Administration of KCNN2 Blocking Peptide Improves Deficits in Cognitive Flexibility in Mouse Model of Fetal Alcohol Spectrum Disorders. (2025)
- Biobank-scale methods and projections for sparse polygenic prediction from machine learning. (2023)
- Kcnn2 blockade reverses learning deficits in a mouse model of fetal alcohol spectrum disorders. (2020)
- PKA and Ube3a regulate SK2 channel trafficking to promote synaptic plasticity in hippocampus: Implications for Angelman Syndrome. (2020)
- SK Channel Modulates Synaptic Plasticity by Tuning CaMKIIα/β Dynamics. (2019)
- Evaluating historical candidate genes for schizophrenia. (2015)
- Genome-wide search for replicable risk gene regions in alcohol and nicotine co-dependence. (2012)
- Association study of 182 candidate genes in anorexia nervosa. (2010)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| kcnn3 | gene | 8 | 13 |
| small-conductance calcium-activated potassium channel gene | gene | — | — |